Leiden Academic Centre for Drug Research
The LACDR represents the core of bio-pharmaceutical research at Leiden University, and we interact closely with our partners:
Study Association L.P.S.V. Aesculapius
In 1885 the "Leiden Pharmaceutical Student Association Aesculapius”, or „Aesculapius” for short, was founded. Since 1985 the student association is linked with the BSc. and MSc. programme's of Bio-Pharmaceutical Sciences.
Leiden Institute of Chemistry (LIC)
The LIC includes research in Chemistry and Life Sciences. Our environment and quality of life is largely determined by chemistry, so teaching and research at the forefront of molecular and life sciences is of great importance for our future.
Centre for Human Drug Research (CHDR)
The CHDR provides a full range of early stage clinical pharmacology services. CHDR specializes in early proof of pharmacology and in the complex process of drug development, we offer an efficient route towards proof of concept in patients. By conducting highly informative early-phase clinical studies, development risks can be minimized and costs can be reduced.
Leiden University Medical Center (LUMC)
LUMC is a modern university medical center for research, education and patient care with a high quality profile and a strong scientific orientation.
ULLA was founded in 1992 as a European Consortium for (Post Graduate) training in the field of Pharmaceutical Sciences. ULLA takes the name from the cities of the founding universities of the consortium, namely Uppsala, London, Leiden and Amsterdam.
Paul Janssen Futurelab Leiden
Paul Janssen Futurelab Leiden is an international training program providing blended learning (online and on-campus) to biomedical professionals with an entrepreneurial spirit. Our mission: to teach a new generation of leaders to develop new medical interventions more efficiently and more effectively.